Neuroprotection Targeting Protein Misfolding on Chronic Cerebral Hypoperfusion in the Context of Metabolic Syndrome
Metabolic syndrome (MetS) is a cluster of risk factors that lead to microvascular dysfunction and chronic cerebral hypoperfusion (CCH). Long-standing reduction in oxygen and energy supply leads to brain hypoxia and protein misfolding, thereby linking CCH to Alzheimer's disease. Protein misfoldi...
Main Authors: | María I. Herrera, Lucas D. Udovin, Nicolás Toro-Urrego, Carlos F. Kusnier, Juan P. Luaces, Matilde Otero-Losada, Francisco Capani |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-05-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2018.00339/full |
Similar Items
-
Neuroprotection from protein misfolding in cerebral hypoperfusion concurrent with metabolic syndrome. A translational perspective
by: Sofía Bordet, et al.
Published: (2023-08-01) -
Palmitoylethanolamide Ameliorates Hippocampal Damage and Behavioral Dysfunction After Perinatal Asphyxia in the Immature Rat Brain
by: María I. Herrera, et al.
Published: (2018-03-01) -
Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease
by: Matilde Otero-Losada, et al.
Published: (2021-12-01) -
Neuroprotection in metabolic syndrome by environmental enrichment. A lifespan perspective
by: Tamara Kobiec, et al.
Published: (2023-08-01) -
Corrigendum: Palmitoylethanolamide attenuates neurodevelopmental delay and early hippocampal damage following perinatal asphyxia in rats
by: Maria I. Herrera, et al.
Published: (2022-12-01)